Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASSOS: OCT Parameters in RRMS with Fingolimod
NCT01705236Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2012
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of fingolimod in multiple sclerosis (MS), sponsored by Novartis. Started Aug 2012; status: completed.
02
Drugs
fingolimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01705236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01705236.